PL2167526T3 - Oczyszczanie czynnika VIII za pomocą żywicy o mieszanej funkcji lub wielofunkcyjnej - Google Patents
Oczyszczanie czynnika VIII za pomocą żywicy o mieszanej funkcji lub wielofunkcyjnejInfo
- Publication number
- PL2167526T3 PL2167526T3 PL08786090T PL08786090T PL2167526T3 PL 2167526 T3 PL2167526 T3 PL 2167526T3 PL 08786090 T PL08786090 T PL 08786090T PL 08786090 T PL08786090 T PL 08786090T PL 2167526 T3 PL2167526 T3 PL 2167526T3
- Authority
- PL
- Poland
- Prior art keywords
- purification
- factor viii
- mixed
- mode
- multimodal resin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07112287 | 2007-07-11 | ||
| EP08786090A EP2167526B1 (en) | 2007-07-11 | 2008-07-11 | Purification of factor viii using a mixed-mode or multimodal resin |
| PCT/EP2008/059094 WO2009007451A1 (en) | 2007-07-11 | 2008-07-11 | Purification of factor viii using a mixed-mode or multimodal resin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2167526T3 true PL2167526T3 (pl) | 2011-09-30 |
Family
ID=38472947
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL08786090T PL2167526T3 (pl) | 2007-07-11 | 2008-07-11 | Oczyszczanie czynnika VIII za pomocą żywicy o mieszanej funkcji lub wielofunkcyjnej |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8399620B2 (pl) |
| EP (1) | EP2167526B1 (pl) |
| JP (1) | JP5323072B2 (pl) |
| KR (1) | KR101293504B1 (pl) |
| CN (1) | CN101730707B (pl) |
| AT (1) | ATE503763T1 (pl) |
| AU (1) | AU2008274195B2 (pl) |
| BR (1) | BRPI0814220B8 (pl) |
| CA (1) | CA2692814A1 (pl) |
| DE (1) | DE602008005885D1 (pl) |
| ES (1) | ES2364118T3 (pl) |
| NL (1) | NL300663I2 (pl) |
| PL (1) | PL2167526T3 (pl) |
| RU (1) | RU2493163C2 (pl) |
| WO (1) | WO2009007451A1 (pl) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5619738B2 (ja) * | 2008-06-24 | 2014-11-05 | オクタファルマ アクチェンゲゼルシャフト | 凝固第ｖｉｉｉ因子の精製方法 |
| MX2011001624A (es) | 2008-08-21 | 2011-03-28 | Octapharma Ag | Factor viii y ix humano producido en forma recombinante. |
| US8945895B2 (en) | 2009-07-31 | 2015-02-03 | Baxter International Inc. | Methods of purifying recombinant ADAMTS13 and other proteins and compositions thereof |
| US8277649B2 (en) | 2009-12-14 | 2012-10-02 | General Electric Company | Membranes and associated methods for purification of antibodies |
| US8974780B2 (en) | 2010-02-24 | 2015-03-10 | Zymenex A/S | Process for production and purification of recombinant lysosomal alpha-mannosidase |
| RU2015149979A (ru) | 2010-03-30 | 2019-01-15 | Октафарма Аг | Способ очистки белка фактора роста |
| WO2011121020A1 (en) | 2010-03-30 | 2011-10-06 | Octapharma Ag | A process for purifying vitamin k dependent proteins such as coagulation factor ix |
| US9422329B2 (en) | 2010-11-05 | 2016-08-23 | Hoffmann-La Roche Inc. | Optimized method for antibody capturing by mixed mode chromatography |
| CA2821711C (en) | 2010-12-15 | 2017-10-10 | Baxter International Inc. | Eluate collection using conductivity gradient |
| WO2013075740A1 (en) | 2011-11-23 | 2013-05-30 | Sanofi | Antibody purification method |
| CN105777862A (zh) | 2012-10-24 | 2016-07-20 | 建新公司 | 使用mes和mops作为流动相改性剂从多峰树脂洗脱生物分子 |
| US10188965B2 (en) | 2012-12-05 | 2019-01-29 | Csl Behring Gmbh | Hydrophobic charge induction chromatographic depletion of a protein from a solution |
| US20140154233A1 (en) | 2012-12-05 | 2014-06-05 | Csl Limited | Method of purifying therapeutic proteins |
| CN103396494B (zh) * | 2013-04-27 | 2015-04-01 | 江苏省疾病预防控制中心 | 一种凝血因子ix的单克隆抗体 |
| TWI631132B (zh) | 2013-05-06 | 2018-08-01 | 賽諾菲公司 | 用於純化抗體之連續多步驟方法 |
| TW201617360A (zh) * | 2014-06-25 | 2016-05-16 | 桂格 史考特 布蘭克 | 用於純化蛋白質之方法及試劑 |
| MX2017000862A (es) | 2014-08-04 | 2017-05-01 | Csl Ltd | Formulacion de factor viii. |
| DK3265483T3 (da) | 2015-03-06 | 2020-03-02 | CSL Behring Lengnau AG | Modificeret von Willebrand-faktor med forbedret halveringstid |
| GB201506117D0 (en) | 2015-04-10 | 2015-05-27 | Ge Healthcare Bio Sciences Ab | Method for chromatography |
| GB201506113D0 (en) | 2015-04-10 | 2015-05-27 | Ge Healthcare Bio Sciences Ab | Method for chromatography |
| EP3205665A1 (en) * | 2016-02-11 | 2017-08-16 | Octapharma AG | Method of separating factor viii from blood products |
| GB201617240D0 (en) * | 2016-10-11 | 2016-11-23 | Profactor Pharma Ltd | Purification process |
| CN111183151B (zh) | 2017-06-23 | 2024-06-07 | 武田药品工业株式会社 | 因子viii亚种的纯化 |
| KR20220029733A (ko) | 2019-07-04 | 2022-03-08 | 체에스엘 베링 렝나우 아게 | 응고 인자 viii의 시험관내 안정성을 증가시키기 위한 절단된 폰 빌레브란트 인자 (vwf) |
| JP2023500953A (ja) | 2019-11-11 | 2023-01-11 | ツェー・エス・エル・ベーリング・レングナウ・アクチエンゲゼルシャフト | 第ｖｉｉｉ因子に対する寛容を誘導するためのポリペプチド |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9302006D0 (sv) * | 1992-10-02 | 1993-06-11 | Kabi Pharmacia Ab | Protein formulation |
| SE9301581D0 (sv) * | 1993-05-07 | 1993-05-07 | Kabi Pharmacia Ab | Protein formulation |
| SE503424C2 (sv) * | 1994-11-14 | 1996-06-10 | Pharmacia Ab | Process för rening av rekombinant koagulationsfaktor VIII |
| IL157309A0 (en) * | 2003-08-07 | 2004-02-19 | Applied Research Systems | Method for the purification of a non-immunoglobulin protein |
| EP1831242B1 (en) * | 2004-12-23 | 2012-09-26 | Novo Nordisk Health Care AG | Reduction of the content of protein contaminants in compositions comprising a vitamin k-dependent protein of interest |
| EP1707634A1 (en) | 2005-03-29 | 2006-10-04 | Octapharma AG | Method for isolation of recombinantly produced proteins |
| JP5619738B2 (ja) | 2008-06-24 | 2014-11-05 | オクタファルマ アクチェンゲゼルシャフト | 凝固第ｖｉｉｉ因子の精製方法 |
-
2008
- 2008-07-11 PL PL08786090T patent/PL2167526T3/pl unknown
- 2008-07-11 CN CN200880023645.XA patent/CN101730707B/zh active Active
- 2008-07-11 KR KR1020107001510A patent/KR101293504B1/ko active IP Right Grant
- 2008-07-11 WO PCT/EP2008/059094 patent/WO2009007451A1/en active Application Filing
- 2008-07-11 EP EP08786090A patent/EP2167526B1/en active Active
- 2008-07-11 ES ES08786090T patent/ES2364118T3/es active Active
- 2008-07-11 CA CA 2692814 patent/CA2692814A1/en not_active Abandoned
- 2008-07-11 JP JP2010515524A patent/JP5323072B2/ja active Active
- 2008-07-11 US US12/668,530 patent/US8399620B2/en active Active
- 2008-07-11 RU RU2010103528/10A patent/RU2493163C2/ru active
- 2008-07-11 AU AU2008274195A patent/AU2008274195B2/en not_active Ceased
- 2008-07-11 BR BRPI0814220A patent/BRPI0814220B8/pt not_active IP Right Cessation
- 2008-07-11 DE DE602008005885T patent/DE602008005885D1/de active Active
- 2008-07-11 AT AT08786090T patent/ATE503763T1/de not_active IP Right Cessation
-
2014
- 2014-04-15 NL NL300663C patent/NL300663I2/nl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2010103528A (ru) | 2011-08-20 |
| BRPI0814220B8 (pt) | 2021-05-25 |
| AU2008274195A1 (en) | 2009-01-15 |
| DE602008005885D1 (de) | 2011-05-12 |
| BRPI0814220A2 (pt) | 2015-01-06 |
| KR20100051620A (ko) | 2010-05-17 |
| AU2008274195B2 (en) | 2013-09-05 |
| ES2364118T9 (es) | 2014-05-19 |
| JP2010533150A (ja) | 2010-10-21 |
| US20100204452A1 (en) | 2010-08-12 |
| CN101730707A (zh) | 2010-06-09 |
| CA2692814A1 (en) | 2009-01-15 |
| KR101293504B1 (ko) | 2013-08-07 |
| CN101730707B (zh) | 2014-12-17 |
| JP5323072B2 (ja) | 2013-10-23 |
| US8399620B2 (en) | 2013-03-19 |
| BRPI0814220B1 (pt) | 2019-09-17 |
| ATE503763T1 (de) | 2011-04-15 |
| RU2493163C2 (ru) | 2013-09-20 |
| EP2167526A1 (en) | 2010-03-31 |
| NL300663I2 (pl) | 2016-09-22 |
| EP2167526B1 (en) | 2011-03-30 |
| WO2009007451A1 (en) | 2009-01-15 |
| ES2364118T3 (es) | 2011-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2167526T3 (pl) | Oczyszczanie czynnika VIII za pomocą żywicy o mieszanej funkcji lub wielofunkcyjnej | |
| AU2016222301A1 (en) | Isolation and purification of antibodies using Protein A affinity chromatography | |
| MX2012004711A (es) | Aislamiento y purificacion de los anticuerpos anti-il-13 al usar cromatografia de afinidad con proteina a. | |
| IL226717A (en) | Isolated nucleic acids encoded by anti-beta human antibodies 7 | |
| WO2009068625A3 (en) | Amino acid sequences directed against her2 and polypeptides comprising the same for the treatment of cancers and/or tumors | |
| GEP20135917B (en) | Stabilized polypeptide compositions | |
| MY162624A (en) | Antibodies directed to her-3 and uses thereof | |
| WO2009147248A3 (en) | Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases | |
| WO2007104529A3 (en) | Amino acid sequences directed against il-6 and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6-mediated signalling | |
| EP1654378A4 (en) | METHODS OF CHEMICAL SYNTHESIS OF CHIMERIC PROTEINS OF IMMUNOGLOBULINS | |
| HK1095749A1 (en) | Novel use of peptide compounds for in production of pharmacenticals for treating central neuropathic pain | |
| MX2010002769A (es) | Preparacion recombinante de fracciones de bromelaina seleccionadas. | |
| NZ781143A (en) | Anti-vegf protein compositions and methods for producing the same | |
| WO2006117782A3 (en) | Recombinant antibodies against cd55 and cd59 and uses thereof | |
| MY151330A (en) | Systems and method for separating proteins from connective tissue | |
| MX2015008875A (es) | Metodos para la purificacion de arilsulfatasa a. | |
| WO2008051178A3 (en) | Purification of proteins with cationic surfactant | |
| WO2010142551A3 (en) | Single variable domain (vhh) antibodies to cytokines of the il-17 receptor family | |
| WO2004002418A3 (en) | Compositions and methods comprising protein activated receptor antagonists | |
| WO2007063129A3 (en) | Insolation of peptides , polypeptides and proteins | |
| ZA202110285B (en) | Antibodies and methods of use | |
| WO2006105490A3 (en) | Compositions and methods for treating diseases associated with phlpp | |
| ATE473999T1 (de) | Polypeptide und nukleinsäuren, die diese codieren | |
| EP4169938A4 (en) | RECOMBINANT PROTEIN PURIFICATION METHOD | |
| IL284402A (en) | A process for the production, isolation and purification of modified recombinant proteins |